✦ LIBER ✦

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

✍ Scribed by S. Cedrés, D. Torrejon, A. Martínez, P. Martinez, A. Navarro, E. Zamora, N. Mulet-Margalef, E. Felip

Book ID: 118822767
Publisher: Springer Milan
Year: 2012
Tongue: Spanish
Weight: 271 KB
Volume: 14
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-012-0872-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1443 POSTER High Blood Neutrophil-to-lym

1443 POSTER High Blood Neutrophil-to-lymphocyte Ratio as an Indicator of Poor Prognosis in Advanced Non Small Cell Lung Cancer

✍ D. Torrejon Castro; S. Cedres; G. Argiles; I. Nunez; V. Rodriguez-Freixinos; N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Cyclin D1 overexpression is an indicator

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer

✍ Keum, J S; Kong, G; Yang, S C; Shin, D H; Park, S S; Lee, J H; Lee, J D 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 289 KB

High kallikrein-related peptidase 6 in n

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis

✍ Heuzé-Vourc’h Nathalie; Planque Chris; Guyetant Serge; Coco Catherine; Brillet B 📂 Article 📅 2009 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 872 KB

Pretreatment neutrophil to lymphocyte ra

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

✍ Yanwen Yao, Dongmei Yuan, Hongbing Liu, Xiaoling Gu… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 247 KB

First-line therapy and methylation statu

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients

✍ Salazar, Fernanda; Molina, Miguel Angel; Sanchez-Ronco, Maria; Moran, Teresa; Ra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Prospective, multicenter, randomized, in

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer

✍ Heigener, David F.; von Pawel, Joachim; Eschbach, Corinna; Brune, Andreas; Schmi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 316 KB